Special rates available for pharmacy owners and practicing pharmacists.
ASAP Conferences Have New Schedule
3:30 – 5:00 Registration5:00 – 6:30 Opening Cocktail Reception
Thursday, June 22
8:00 – 8:45 Continental Breakfast
8:45 – 9:00 Gold Sponsor Podium Time
9:00 – 9:45 Adverse Drug Events, the Perpetual Medication-Related Public Health Chasm: Who Is the Rightful Bridge-Builder?
Cal Knowlton, B.Sc.Pharm., Ph.D., CEO & Founder, Tabula Rasa HealthCare
We wonder why adverse drug events (ADEs) cause more than 100,000 deaths per year, increase 10% of hospital stays by two to five days, and interfere with quality of life for millions of people. For over 30 years, traditional pharmacy software systems have offered clinicians a binary view of drug-to-drug interactions, presenting a superficial assessment of one single drug against one single drug. Tabula Rasa HealthCare (THRC) has developed a medication risk mitigation (MRM) software platform that delivers a simultaneous, multidrug point-of-care analysis, which identifies medication risk across a variety of safety factors and presents meaningful opportunities to mitigate that risk. Learn about how health plans and provider groups have reduced ADEs, pharmacy spend, falls, and hospitalizations with pharmacists who incorporate an MRM platform.
9:45 – 10:15 Drug Utilization Edits: Failures, Needs, and Future Direction
Tim Kosty, RPh. M.B.A., President, Pharmacy Healthcare Solutions, Inc.
The Chicago Tribune published an editorial on Dec. 16, 2016, entitled, “Dispensing danger: How pharmacies fail to warn patients of toxic drug interactions.” The Tribune sent “patients” to 255 Chicago-area pharmacies with prescriptions that had serious drug-drug interactions to determine how the pharmacists would counsel and warn patients about potential risks. The results were disappointing, as 52% of the prescriptions were dispensed without mentioning potential interactions, putting patients at risk.Tim’s presentation will review a variety of issues, including historical implementation of DUR edits, pharmacy workflow considerations, choices made by pharmacy chain management to display/suppress messages, payers’ choices on DUR messaging in their claims processing systems, alert fatigue, evidence-based versus theoretical interactions, legal implications, and future strategies and tactics. He’ll address these from stakeholder perspectives, including drug compendia, chain headquarters, payer, and pharmacist. After the Tribune editorial, an Illinois state legislator introduced a bill to make dramatic changes to pharmacy practice. Tim will also review this proposed solution and discuss strategies to improve the effectiveness of DUR edits and tactics to monitor performance.
10:15 – 10:45 The Future of Prescription Drug Monitoring Programs (PDMPs): Highlights of 2017 State Bills
Sherry Green, President, National Alliance for Model State Drug Laws (NAMSDL)
Sherry will explain how state legislators are shaping the future operations of prescription drug monitoring programs (PDMPs) through key changes adopted in 2017 state bills. She will take an in-depth look at mandated registration, mandated use, frequency of reporting, and other legislative amendments designed to transform PDMPs into better health and safety tools.
10:45 – 11:00 Break
11:00 – 11:30 Managing Cybersecurity Risk While Connecting Healthcare
Bill Alfveby, Chief Information Security Officer, Surescripts
It has long been a goal of healthcare to allow different stakeholders to easily share information electronically. The advantages are nearly universal. Patients and providers benefit from quick medical histories at providers’ fingertips. Providers can quickly get coverage information from payers. Prescribers, payers, and pharmacies can all share nearly instantaneous information on formularies, eligibility, and prescriptions. This connectivity also means that each of the connected entities needs to protect the confidentiality, integrity, and availability of its data, and each must also have some trust, and potentially requirements, for the other entities in the network. Bill’s presentation will discuss what makes a good cybersecurity program, how to manage third-party risk, and some of the proactive and reactive things organizations can do in a connected network.
11:30 – 12:00 ePA: Technology Advances and Emerging Legislative Requirements
Perry Lewis, Vice President of Industry Relations, CoverMyMeds
The majority of prior authorization (PA) requests are still initiated at the pharmacy, while the number of PAs continues to increase due to specialty and legislative initiatives. Nearly every pharmacy system in the market provides an electronic prior authorization, or ePA, solution in the pharmacy workflow. At present, 23 states have implemented legislation relating to the PA process. These laws range from the use of standardized forms for submission to mandating the use of the NCPDP SCRIPT ePA standard transactions. Perry will provide an overview of pharmacies engaged in PA processes, state requirements, and the best way for pharmacists to assist with compliance.
12:00 – 1:30 Lunch
1:30 – 5:30 Networking and Business Meetings5:30 – 7:00 President’s Reception
8:00 – 8:45 Continental Breakfast
8:45 – 9:00 Midyear Report on ASAP Activities
9:00 – 9:30 Use of the Pharmacist eCare Plan in a Statewide Community Pharmacy Network
Trista Pfeiffenberger, Pharm.D., M.S., Director, Network Pharmacy Programs, Community Care of North Carolina
Pharmacies participating in a statewide North Carolina Community Pharmacy Enhanced Services Network will be implementing Pharmacist eCare Plans in conjunction with a value-based payment model tested as part of a Centers for Medicare and Medicaid Services Health Care Innovation Award. Trista will share details about previous barriers to care plan documentation, the strategy for eCare Plan implementation, and initial learnings from the eCare Plan implementation.
9:30 – 10:00 IBM Watson: Artificial Intelligence Meets Healthcare
Brent Fox, Pharm.D., Ph.D., Associate Professor, Auburn University Harrison School of Pharmacy
We are told that change is a normal part of life. In the information technology space, we know that change comes rapidly. In everyday life, we’ve arrived at a point when those who are really famous are known by a single name. Think Prince, Oprah, Ronaldo, and…Watson. IBM’s Watson has demonstrated great potential to meet healthcare’s demands to make sense of the ever-expanding universe of data. Brent will describe Watson’s foundations, notable experiences to date in healthcare, and what the future may hold as the use of artificial intelligence expands in healthcare.
10:00 – 10:15 Break
10:15 – 10:45 21st Century Cures Act: Accelerating Discovery, Development, and Delivery
Marsha Millonig, M.B.A., B.Pharm., President & CEO, Catalyst Enterprises
The 21st Century Cures Act (Public Law 114-255) has an incredibly wide scope of provisions that aims to improve Americans’ healthcare by accelerating the discovery, development, and delivery of medical products. The law is a combination of a number of legislative initiatives. Areas addressed in the act include spurring new cancer cures, improving mental health, and combating opioid addiction. Marsha will provide you with a glimpse of key highlights of the act that range across the discovery and delivery spectrums, including patient privacy and HIT interoperability. No one will be left untouched by the act, and you’ll hear why.
10:45 – 11:15 Biologics and Biosimilars: Regulatory and Dispensing Requirements Impacting Pharmacy and Pharmacy Systems
Thomas Felix, M.D., Medical Director, Global Regulatory Affairs and Safety, Amgen
The rapid expansion of biologics and the recent introduction of biosimilars to the U.S. healthcare market represents an exciting public health opportunity. While offering an opportunity to lower healthcare costs, the introduction of these products has also triggered a significant amount of analysis and scrutiny from legislative and regulatory bodies around patient safety and access to these products. The goal of this session is to provide an overview of the landscape of biologics and biosimilars, along with an in-depth analysis and discussion of current state and federal regulations surrounding these products that impact pharmacies and pharmacy systems. Specific information will be provided related to state regulations for the required communication between a pharmacy and a provider in the case of biologic or biosimilar substitution, along with an analysis of existing standards to allow for the electronic communication of this information.
11:15 – 11:45 Specialty Pharmacy: Inside the Innovation
Tim Davis, Pharm.D., General Manager, PANTHERx Specialty Pharmacy
Operating a specialty pharmacy has its own challenges that separate it from standard retail pharmacy — from specific reporting needs and data elements to making sure the pharmacy outperforms accreditation standards. Tim, one of the founders of Pittsburgh-based specialty pharmacy PANTHERx, will share his experiences to date in this space, and where he sees demand for specialty technology tools to support the patient care mission and business needs of pharmacies in this category.